The Team
Our team of 8 specialist consultants with our Associates and Advisory Board, based in offices in Cambridge, UK, work with clients - from Pharma to start-ups, Angels to Hedge funds, hospitals to Universities - to develop the products and services which are shaping modern medicine. We have been involved in the establishment and financing of a number of the UK's leading biomedical ventures.
As a leading pioneer of 'Translational Medicine' in the UK, we have been in the vanguard of the biomedical revolution that is changing the way healthcare is delivered. In 2005/6 we co-ordinated the business planning and establishment of the £50m 'Translational Medicine Research Institute' (TMRI) in Scotland, and have subsequently advised on a number of other groundbreaking translational partnerships between Hospitals and Academic Institutes.
Our team includes scientists, medics, and financial expertise, and we have a strong commitment to linking long term strategic analysis of trends and sectors with hands-on transaction support: helping to make things happen.
Consulting Director
- George Freeman
Principal Consultants
- Julie Barnes
- Chris Hodkinson
- Dr. William Bains
- Hakim Yadi
- Dr. Christopher Rumball
- Prof. Martin Wehling
- Andrew Williams
-
Miranda Weston-Smith
Advisory Board
- Simon Cartmell
- Dr. David Cotterell
- Dr. Ann Hayes
- Peter Keen
- Dr. Andy Richards
- Simon Kerr
- Prof. Martin Wehling
-
Bryan Morton
Our aim at 4D Biomedical is to combine highly professional consulting with the responsiveness of a dynamic team. We are transaction and value focussed and understand that clients need a service which is prompt, accurate, insightful and commercial. We have support and project research staff but all projects are handled by senior consultants. In our experience the most valuable advisory services are those that are based on long term relationships; so we value and work hard to protect our client base and track record.
Intelligence
Advice is only as good as the Intelligence it is based on.
We have alliances with two leading data specialists in private equity and pharmaceutical markets.
Apex Healthcare Consulting